{
    "clinical_study": {
        "@rank": "156260", 
        "arm_group": [
            {
                "arm_group_label": "Milk with Bifidobacteria", 
                "arm_group_type": "Experimental", 
                "description": "duration of the treatment is 5 months"
            }, 
            {
                "arm_group_label": "Milk with non replicating lactobacilli", 
                "arm_group_type": "Active Comparator", 
                "description": "duration of the treatment is 5 months"
            }, 
            {
                "arm_group_label": "Semi skimmed milk", 
                "arm_group_type": "Placebo Comparator", 
                "description": "duration of the treatment is 5 months"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the effect of milk-based formulas on infections and immune functions in\n      healthy children."
        }, 
        "brief_title": "Children Immune Functions(2)", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Diarrhea", 
            "Upper Respiratory Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diarrhea", 
                "Respiratory Tract Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "Particular attention was paid to the role played by nutrition in supporting the gut\n      ecosystem, balancing microbiota and promoting health status. In that respect, the beneficial\n      effects of probiotics were demonstrated for different infectious diseases, GII and URI.\n\n      The beneficial effect of probiotics for treatment of symptomatic diarrhea was clearly\n      documented."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Parents written and signed informed consent for participation in the study.\n\n          -  Healthy children aged 1 to 3 years that are no more breastfed.\n\n          -  Go to a selected nursery and / or pediatrician.\n\n          -  Parents must have a phone at home or a cellular phone to call the paediatrician.\n\n          -  No consumption of commercial products containing probiotics or prebiotics during the\n             3 weeks before and during the study period.\n\n          -  Parents are able to give their children, twice daily, 2 milk servings  on a 5 months\n             period.\n\n          -  Children not being intensive consumers of regular yoghurts\n\n        Exclusion Criteria:\n\n          -  Rotavirus and flu vaccines administration within the last 3 months prior to V1\n             (baseline visit).\n\n          -  Used antibiotics within the last 30 days prior to V1 (baseline visit).\n\n          -  Congenital or chronic disease.\n\n          -  Any kind of immunodeficiency or allergy, milk protein allergy or lactose intolerance.\n\n          -  Significant illness within the two weeks prior to start of the study or any active\n             systemic infection or medical condition that may require treatment or therapeutic\n             intervention during the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "3 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "604", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01731392", 
            "org_study_id": "10.50.NRC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Milk with Bifidobacteria", 
                "description": "A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.", 
                "intervention_name": "Milk with Bifidobacteria", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Milk with non replicating lactobacilli", 
                "description": "A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.", 
                "intervention_name": "Milk with non replicating lactobacilli", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Semi skimmed milk", 
                "description": "A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.", 
                "intervention_name": "placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Diarrhea", 
            "Children", 
            "Lactobacilli"
        ], 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jakarta", 
                    "country": "Indonesia"
                }, 
                "name": "Dept. Nutrition, Faculty of Medicine University of Indonesia"
            }
        }, 
        "location_countries": {
            "country": "Indonesia"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Milk-based Formulas on Infections and Immune Functions in Healthy Children", 
        "overall_official": {
            "affiliation": "Nutrition Department, Faculty of Medicine,", 
            "last_name": "Saptawati Bardosono, MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Indonesia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Days with diarrhea", 
            "safety_issue": "No", 
            "time_frame": "during the 5 months of follow up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01731392"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of episodes of Upper Respiratory Infections", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "measure": "Duration of episodes of Upper Respiratory Infections", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "measure": "Severity of episodes of Upper Respiratory Infections", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}